Succinylcholine Chloride Injection, Solution
Product Images NDC 55150-315

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 55150-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg per 10 mL (20 mg / mL))

Package Label-principal Display Panel (200 mg per 10 mL (20 mg / mL))
This text appears to be a description of a medication. It is labeled as a paralyzing agent and warns of causing respiratory arrest. It contains various substances such as methylparaben, propylparaben, sodium chloride, and pH adjusters. The medication is in the form of an injection and is sterile and nonpyrogenic. It should be stored at a temperature of 2° to 8°C and used with aseptic technique. The dosage is 200 mg per 10 mL. The medication is intended for intravenous or intramuscular use. The expiration information is not readable in the text.*
FDA Label Image

Package Label-principal Display Panel (200 mg per 10 mL (20 mg / mL) – Container-Carton (25 Vials))

FDA Label Image

Succinylcholine-figure-3 (Succinylcholine Fig3)

FDA Label Image

Chemical-structure (Succinylcholine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.